REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 242 filers reported holding REPLIGEN CORP in Q4 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $76,154,961 | -17.4% | 449,796 | -8.7% | 0.02% | -28.0% |
| Q3 2022 | $92,198,827 | +10.0% | 492,752 | -4.5% | 0.02% | +13.6% |
| Q2 2022 | $83,814,965 | -18.4% | 516,102 | -5.4% | 0.02% | 0.0% |
| Q1 2022 | $102,657,077 | -26.1% | 545,787 | +4.1% | 0.02% | -24.1% |
| Q4 2021 | $138,881,000 | -4.5% | 524,394 | +4.2% | 0.03% | -9.4% |
| Q3 2021 | $145,482,000 | +46.1% | 503,417 | +0.9% | 0.03% | +45.5% |
| Q2 2021 | $99,555,000 | +22.8% | 498,723 | +19.6% | 0.02% | +15.8% |
| Q1 2021 | $81,065,000 | +0.3% | 416,981 | -1.2% | 0.02% | 0.0% |
| Q4 2020 | $80,850,000 | +41.5% | 421,909 | +9.0% | 0.02% | +26.7% |
| Q3 2020 | $57,124,000 | +2.8% | 387,177 | -13.9% | 0.02% | -6.2% |
| Q2 2020 | $55,587,000 | +20.8% | 449,698 | -5.7% | 0.02% | 0.0% |
| Q1 2020 | $46,014,000 | +4.4% | 476,630 | 0.0% | 0.02% | +33.3% |
| Q4 2019 | $44,088,000 | +18.9% | 476,630 | -1.4% | 0.01% | +9.1% |
| Q3 2019 | $37,085,000 | -0.5% | 483,573 | +11.5% | 0.01% | -8.3% |
| Q2 2019 | $37,265,000 | +56.3% | 433,573 | +7.4% | 0.01% | +50.0% |
| Q1 2019 | $23,843,000 | +29.9% | 403,573 | +16.0% | 0.01% | +14.3% |
| Q4 2018 | $18,352,000 | -4.9% | 347,964 | 0.0% | 0.01% | +16.7% |
| Q3 2018 | $19,298,000 | +17.9% | 347,964 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $16,368,000 | +46.4% | 347,964 | +12.6% | 0.01% | +50.0% |
| Q1 2018 | $11,177,000 | -39.5% | 308,951 | -39.4% | 0.00% | -42.9% |
| Q4 2017 | $18,484,000 | -5.3% | 509,497 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $19,524,000 | -2.2% | 509,497 | +5.8% | 0.01% | -12.5% |
| Q2 2017 | $19,960,000 | +39.4% | 481,667 | +18.4% | 0.01% | +33.3% |
| Q1 2017 | $14,315,000 | +67.9% | 406,667 | +47.0% | 0.01% | +50.0% |
| Q4 2016 | $8,527,000 | +6.9% | 276,667 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $7,978,000 | +5.4% | 276,667 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $7,570,000 | +2.0% | 276,667 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $7,420,000 | +9.5% | 276,667 | +15.5% | 0.00% | +33.3% |
| Q4 2015 | $6,774,000 | +1.7% | 239,440 | +0.1% | 0.00% | 0.0% |
| Q3 2015 | $6,660,000 | – | 239,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |